BioWorld

May 18, 2010

View Archived Issues

Astellas Acquires OSI for $4B; Sweetened Bid Melts Hostility

After an unsuccessful $3.5 billion hostile takeover attempt, Astellas Pharma Inc. raised its acquisition offer for OSI Pharmaceuticals Inc. to $4 billion, and OSI agreed to a friendly buyout. (BioWorld Today) Read More

ARCA Shares Get a Bounce on SPA OK for Beta-Blocker

Read More

Roxro Dodges Opioid, NSAID Traps; 'Smooth' Nod for Sprix

Read More

NewCo News: ElexoPharm's First License Deal Worth up to $41.6M from Merck

Read More

NuPathe Files for $86M IPO Ahead of Migraine Patch NDA

Read More

Clinic Roundup

Read More

Stock Movers

Read More

Other News To Note

Read More

ATS Roundup

Read More